Table 2 Univariate Cox regression between genomic alterations and recurrence after BCG therapy

From: The role of TERT C228T and KDM6A alterations and TME in NMIBC treated with BCG

Variable

HR

P value

HRD (High vs Low)

2.55 [1.01–6.41]

0.0394

PTPN11 (Mut vs WT)

4.57 [1.25–16.74]

0.0113

NF2 (Mut vs WT)

3.97 [1.13–13.92]

0.0194

TERT C228T (Yes vs No)

2.74 [1.1–6.84]

0.0242

KDM6A (Mut vs WT)

2.51 [1.01–6.21]

0.0395

  1. BCG bacillus Calmette-Guérin, HR hazard ratio, Mut mutation.
Back to article page